This Project Grant award for $901,906 from the Defense Health Agency supports research to develop "AUTOMATIC RAPID, HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA". The funding is provided through the Military Medical Research and Development program (CFDA 12.420) which focuses on biomedical research to address military and veteran health needs. The research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,594,419.00 to The Regents of the University of California, San Francisco (UCSF) to conduct radiopathomic mapping of tumor burden for personalized management of IDH-mutant glioma. The award period runs from September 1, 2025 to August 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in translational...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $574,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on "Targeting and Imaging Vitamin B5 Metabolism in Diffuse Midline Gliomas". The award period runs from Sep 1, 2025 to Aug 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in biomedical research,...
This $2,794,450 federal Project Grant award from the U.S. Department of Defense's Military Medical Research and Development Program (CFDA 12.420) supports the development of an automated, rapid, high-resolution metabolic imaging system to improve management of patients with glioma brain tumors. The primary awardee, The Regents of the University of California, San Francisco (UCSF), is collaborating with Bogazici Universitesi in Turkey as a sub-grantee to develop deep learning algorithms for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $328,000.00 in funding to The Regents of the University of California, San Francisco (UCSF) to investigate intracalvarial drug delivery strategies into skull bone marrow to create an antitumoral myeloid cell immune response to glioblastoma. The award period is from July 1, 2025 to June 30, 2027. As a leading academic medical center and research...
This federal Project Grant award for $2,720,383 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of California, San Francisco (UCSF) to investigate "Imaging Cardiac Metabolic Flux and Mitochondrial Function by Hyperpolarized 13C and CEST Metabolic Magnetic Resonance Imaging." The 4-year award period runs from July 2025 to July 2029 and aims to transform healthcare for...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The Regents of the University of California, San Francisco will receive $1,983,742 through a three-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will support research integrating metabolic and physiologic magnetic resonance imaging (MRI) techniques for personalized glioblastoma radiotherapy planning from September 1, 2022 to August 31, 2025. Through this funding, researchers at the University of...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...